Loading…
Loading…
ADAP (Adaptimmune Therapeutics plc) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
| ANL | Adlai Nortye Ltd. | $15.06 | $799.4M |
| THAR | Tharimmune, Inc. | $3.54 | $139.9M |
| APLM | Apollomics, Inc. | $26.20 | $57.5M |
| LPCN | Lipocine Inc. | $2.15 | $17.7M |
| BLRX | BioLineRx Ltd. | $2.70 | $11.7M |
| LNAI | Lunai Bioworks Inc. | $2.40 | $10.9M |
| GOVX | GeoVax Labs, Inc. | $0.63 | $4.6M |
| OSRH | OSR Holdings, Inc. | $0.12 | $3.9M |
| MBRX | Moleculin Biotech, Inc. | $0.60 | $3.2M |
| ERNA | Ernexa Therapeutics Inc. | $4.89 | $1.5M |